K Nn mK - Amecamex.org.mx
K Nn mK - Amecamex.org.mx
K Nn mK - Amecamex.org.mx
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Graphic 3 presents the initial and<br />
final values of glucose, but now of<br />
the group of diabetic people with<br />
their respective treatments, in this<br />
case it is possible to see that<br />
significant differences between<br />
the groups do not exist, it is to say<br />
that the marmalade and the diet<br />
did not caused any effect on the<br />
glucemia since there’s not a<br />
statistical difference between<br />
them. The individuals that were<br />
included in this group did know<br />
that they were diabetic and in<br />
most cases they already had<br />
taken a pharmacological<br />
treatment and so their glucemia<br />
could be the reflex of these<br />
treatments rather than the<br />
marmalade. In this case the<br />
marmalade effect is not clear and<br />
it doesn’t seem to increase the effect of the medicaments<br />
CONCLUSION<br />
220<br />
205<br />
190<br />
175<br />
160<br />
145<br />
130<br />
115<br />
100<br />
85<br />
FSB1-2004<br />
Food Science and Biotechnology in Developing Countries<br />
GRAPHIC 3. Initial and final glucemia in<br />
diabetic subjects<br />
This cactus marmalade can decrease the glucose levels in altered peoples but not in diabetic people.<br />
This marmalade will can be an alternative for decreasing the glucose levels in peoples with glucemia<br />
alteration, to satisfy the sweet necessity, improvement the glucose levels and to delaying the diabetic<br />
mellitus appearance. Exist a complicated for work with diabetics patients owing to the control in not<br />
the 100 percent, generally the peoples is influenced for the environment in the found, and this<br />
peoples not follow to prescribe of adequate manner. Is important to continue with is study of the nopal<br />
marmalade effects on the glucose levels in a sample major of patients, to validate the results and<br />
determinate the product beneficial in subjects which present glucose tolerance alteration.<br />
REFERENCES<br />
1. González-Villalpando C, Martínez DS, Arredondo PB, et al. 1996. Factores de riesgo<br />
cardiovascular en la Ciudad de México. Estudio en población abierta urbana. Rev. Med.<br />
IMSS. 34:461-6.<br />
2. American Diabetes Association. 2000. Screening for type 2 Diabetes. Diabetes Care Vol. 23.<br />
suplement 1.<br />
3. Carmena R. 2000. Diabetes y riesgo cardiovascular. Diabetes Care. Suplemento de la edición<br />
en español. Julio:22.<br />
4. Chandalia M, et al. 1974. Dietary Fiber and disease. Ed. Jama: 1068-1074<br />
5. Vázquez CI, Jiménez A. 1999. Servicio de aparato digestivo. Hospital Universitario de la<br />
Princesa. Prescripción de Fármacos, 5(4).<br />
6. Food and Drug Administration (FDA), 1998. Food additives permitted for direct addition to<br />
food for human consumption; sucralose, 63(64), rules and regulations: 16417-16433.<br />
7. Rojas HE. 1991. La dieta del diabético. En: Revista Clínica Española. 188(5):221-222.<br />
Tratamiento dietético en la diabetes mellitus artículo escrito por Teresa Motilla Valeriano y<br />
Carmen Martín Salinas.<br />
T0<br />
T1<br />
T2